Posted by: Market Watch in Market Information 2 hours in the past Shares of Johnson & Johnson gained 1.2% in after-hours buying and sel
Shares of Johnson & Johnson gained 1.2% in after-hours buying and selling on Thursday after the corporate introduced that it had submitted an software for an emergency use authorization to the Meals and Drug Administration for its COVID-19 vaccine candidate. The experimental single-dose COVID vaccine was 72% efficient at stopping symptomatic illness within the U.S. arm of the Part three scientific trial, in response to findings launched Jan. 29. The FDA is anticipated to schedule a gathering of an advisory committee that may vote on whether or not the advantages of the vaccine outweigh the dangers, as was finished previous to the emergency use authorizations of BioNTech SE /Pfizer Inc. and Moderna Inc.’s COVID-19 vaccines. The corporate additionally mentioned Thursday that its vaccine might be saved for 2 years at adverse 4 levels Fahrenheit in most traditional fridges, and that it will probably present 100 million doses of its vaccine candidate within the U.S. within the first half of 2021. J&J’s inventory has gained 6.8% over the previous 12 months, whereas the broader S&P 500 is up 17.9%.Market Pulse Tales are Speedy-fire, brief information bursts on shares and markets as they transfer. Go to MarketWatch.com for extra info on this information.
Learn Full Story
